Smoldering Plasma Cell Myeloma
Showing 1 - 11 of 11
Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester
Recruiting
- Plasma Cell Myeloma
- +3 more
- Bone Marrow Biopsy
- +3 more
-
Phoenix, Arizona
- +2 more
Jan 18, 2023
Smoldering Plasma Cell Myeloma Trial in United States (biological, drug, other)
Recruiting
- Smoldering Plasma Cell Myeloma
- Daratumumab
- +4 more
-
Anchorage, Alaska
- +595 more
Dec 7, 2022
Quality of Life in Asymptomatic Monoclonal Gammopathies
Recruiting
- Monoclonal Gammopathy of Undetermined Significance
- Smoldering Plasma Cell Myeloma
- Quality-of-Life Assessment
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Oct 25, 2022
Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo (behavioral, drug, other)
Recruiting
- Plasma Cell Myeloma
- +3 more
- Behavioral Intervention
- +6 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 5, 2022
Smoldering Plasma Cell Myeloma Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)
Active, not recruiting
- Smoldering Plasma Cell Myeloma
- Laboratory Biomarker Analysis
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Mar 23, 2022
Smoldering Plasma Cell Myeloma Trial in Houston (procedure, drug, biological)
Recruiting
- Smoldering Plasma Cell Myeloma
- Biopsy Specimen Radiography
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 12, 2021
Progression to Myeloma in Asymptomatic Monoclonal Gammopathies
Recruiting
- Monoclonal Gammopathy of Undetermined Significance
- Smoldering Plasma Cell Myeloma
- Biospecimen Collection
- Laboratory Biomarker Analysis
-
Houston, TexasM D Anderson Cancer Center
Oct 4, 2021
Light Chain Deposition Disease, Smoldering Plasma Cell Myeloma Trial in Ireland, Puerto Rico, United States (Clinical
Active, not recruiting
- Light Chain Deposition Disease
- Smoldering Plasma Cell Myeloma
- Clinical Observation
- Lenalidomide
-
Anchorage, Alaska
- +612 more
Apr 29, 2021
Indolent Plasma Cell Myeloma, Plasma Cell Myeloma, Smoldering Plasma Cell Myeloma Trial in Rochester (biological, drug, other)
Completed
- Indolent Plasma Cell Myeloma
- +2 more
- Anakinra
- +4 more
-
Rochester, MinnesotaMayo Clinic
Mar 13, 2020
Smoldering Plasma Cell Myeloma Trial in Duarte (Leflunomide, Quality-of-Life Assessment, Questionnaire Administration)
Withdrawn
- Smoldering Plasma Cell Myeloma
- Leflunomide
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 12, 2019
Plasma Cell Myeloma, Plasmacytosis, Recurrent Plasma Cell Myeloma Trial in Aurora (Melphalan, Bortezomib, Dexamethasone)
Terminated
- Plasma Cell Myeloma
- +3 more
- Melphalan
- +3 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Feb 23, 2015